Category: MS Research Study and Reports

Study Supported by the National Multiple Sclerosis Society Sheds Light on the Brain’s Ongoing Effort to Create Myelin-Making Cells

January 29, 2026 Researchers from Johns Hopkins Medicine discovered that the brain is continually trying to produce myelin-making cells. Supporting…

Stuart Schlossman

EBV can trick the immune system to attack myelin in at-risk individuals

Study shows how a common virus and genetic risk factors interact to trigger MS Written by Marisa Wexler, MS | January 15, 2026…

Stuart Schlossman

Immune Signal Ratio May Predict Progressive Multiple Sclerosis

January 2, 2026 Summary: A long-term study has identified a potential biomarker that could help detect which patients are progressing toward…

Stuart Schlossman

Multiomics integration prioritizes potential drug targets for multiple sclerosis

Significance We tested hundreds of multiple sclerosis (MS)-associated proteins in plasma and brain and confirmed the potential causal role of…

Stuart Schlossman

Perceived Pain during Isometric Exercise and Neuromuscular Fatigability in Individuals with Multiple Sclerosis

Oct 2025 Highlights • How pain during exercise relates to neuromuscular fatigability in MS is unclear • Smaller changes in…

Stuart Schlossman

Four distinct paths of disability progression emerge in relapsing MS

Findings may help explain why symptoms worsen even without relapses Written by Marisa Wexler, MS | December 24, 2025 Disability progression in relapsing…

Stuart Schlossman

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food…

Stuart Schlossman

Treatment effects of monthly intravenous immunoglobulin on patients with relapsing – remitting Multiple Sclerosis: Further analyses of the Austrian immunoglobulin in MS Study

Abstract Recently, the Austrian Immunoglobulin in Multiple Sclerosis (AIMS) study showed patients with relapsing – remitting multiple sclerosis to benefit…

Stuart Schlossman

CONNECT with Our MS Community Chat

Connect to a Forum for MS “lived” experiences From anywhere, interface with People who understand MS. Join us so you…

Stuart Schlossman

Common virus jab could be key in fight against multiple sclerosis

The vaccine will be trialled in patients recently diagnosed with MS By Jane Kirby – Wednesday 19 November 2025 A…

Stuart Schlossman

Categories

Latest Blog Posts